Načítá se...
Amending microbiota by targeting intestinal inflammation with TNF blockade attenuates development of colorectal cancer
Intestinal inflammation and microbiota are two important components of colorectal cancer (CRC) etiology. However, it is not clear how tuning inflammation using clinically relevant anti-inflammatory treatment impacts microbiota or whether this consequently influences CRC outcome. Here, using chemical...
Uloženo v:
| Vydáno v: | Nat Cancer |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7990316/ https://ncbi.nlm.nih.gov/pubmed/33768208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s43018-020-0078-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|